| # | Drug | Count |
|---|---|---|
| 0 | LEVOTHYROXINE SODIUM | 178 |
| 1 | CABOZANTINIB | 107 |
| 2 | ERGOCALCIFEROL | 73 |
| 3 | PEMBROLIZUMAB | 68 |
| 4 | NIVOLUMAB | 51 |
| 5 | ACETAMINOPHEN | 47 |
| 6 | AMLODIPINE | 44 |
| 7 | LEVOTHYROXINE SODIUM ANHYDROUS | 44 |
| 8 | GABAPENTIN | 39 |
| 9 | OMEPRAZOLE MAGNESIUM | 38 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ARNICA MONTANA, CARDUUS MARIANUS, DAMIANA, GALIUM APARINE, HAMAMELIS VIRGINIANA, HEPAR SUIS, HYPOPHYSIS SUIS, PANAX GINSENG, L-ARGININE, OLEUM ANIMALE, SCHISANDRA CHINENSIS, TARAXACUM OFFICINALE, THUJA OCCIDENTALIS | 1 | 0.0588 |
| 1 | VILTOLARSEN | 1 | 0.0059 |
| 2 | FERROUS FUMARATE AND POLYSACCHRIDE IRON VITAMIN MINERAL COMPLEX SUPPLEMENT | 1 | 0.0051 |
| 3 | PSYLLIUM HUSK | 6 | 0.0044 |
| 4 | ERGOCALCIFEROL | 73 | 0.0025 |
| 5 | MEXILETINE HYDROCHLORIDE | 1 | 0.0024 |
| 6 | TINIDAZOLE | 1 | 0.0023 |
| 7 | CABOZANTINIB | 107 | 0.0022 |
| 8 | NIVOLUMAB AND RELATLIMAB-RMBW | 1 | 0.0019 |
| 9 | DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE | 1 | 0.0019 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 77 |
| 1 | Corticosteroid [EPC] | 65 |
| 2 | Benzodiazepine [EPC] | 59 |
| 3 | Kinase Inhibitor [EPC] | 56 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 52 |
| 5 | Vitamin C [EPC] | 47 |
| 6 | Dihydropyridine Calcium Channel Blocker [EPC] | 45 |
| 7 | Calcium Channel Blocker [EPC] | 44 |
| 8 | GLP-1 Receptor Agonist [EPC] | 43 |
| 9 | Proton Pump Inhibitor [EPC] | 42 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lymphocyte Activation Gene-3 Blocker [EPC] | 1 | 0.0019 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 33 | 0.0017 |
| 2 | Leptin Analog [EPC] | 1 | 0.0008 |
| 3 | Estrogen Agonist/Antagonist [EPC] | 2 | 0.0008 |
| 4 | Pyrethroid [EPC] | 1 | 0.0006 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 52 | 0.0005 |
| 6 | Thyroid Hormone Synthesis Inhibitor [EPC] | 5 | 0.0005 |
| 7 | Ergot Derivative [EPC] | 2 | 0.0004 |
| 8 | mu-Opioid Receptor Agonist [EPC] | 1 | 0.0003 |
| 9 | RNA Synthetase Inhibitor Antibacterial [EPC] | 4 | 0.0003 |